Bladder Cancer Clinical Trials

ReadTheTrial indexes 4 studies for Bladder Cancer. The most common development stage is Phase 2 (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

4 clinical trials found for Bladder Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
75%
N/A 1
25%

Trial Status Breakdown

Trials for Bladder Cancer

Phase 1/2 Study of Intravesical MK-3120 in BCG-Naïve or BCG-Exposed High-Risk Non-muscle Invasive Bladder Cancer

NCT07222488 · RECRUITING · Phase 2

External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors (ESPERANZA)

NCT06973161 · COMPLETED · N/A

Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

NCT04138628 · ACTIVE NOT RECRUITING · Phase 2

Phase II Safety and Efficacy Study of CG0070 Oncolytic Vector Regimen in Patients With High Grade Non-Muscle Invasive Bladder Carcinoma Disease (NMIBC) Who Have Failed BCG and Refused Cystectomy

NCT02143804 · WITHDRAWN · Phase 2

Frequently Asked Questions

What clinical trials are available for Bladder Cancer?

There are 4 clinical trials listed for Bladder Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Bladder Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Bladder Cancer trials in?

Current Bladder Cancer trials are distributed across: Phase 2 (3), N/A (1).

Find More Trials